• Cancer Antigen (CA) 19-9, Serum
  • Colon Cancer Multi-Gene Panel, NGS (ColoNext®, COLONSEQ, COLONSEQPlus)
  • MSH6 Gene Mutation Analysis (Known Mutations, Duplication/Deletion/Sequencing)
  • Myelodysplastic syndrome
  • Dihydropyrimidine Dehydrogenase (DPYD) Genotyping
  • The BT-Reveal Early Pancreatic Cancer Test
  • Fibrinogen (Functional)
  • Oncology Pharmacogenetics (PGx) Gene Variation Panel
  • C-Reactive Protein, High Sensitivity (hsCRP)
  • FoundationOne®CDx (F1CDx) and FoundationOne® Liquid CDx
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /The BT-Reveal Early Pancreatic Cancer Test
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

The BT-Reveal Early Pancreatic Cancer Test
Medical Test

Additional Testing
Access to The BT-Reveal Early Pancreatic Cancer Test is restricted.
Loading...